RACHEL POTTER: Open Payments
NPI 1770063703 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $78 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 6 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Vantive US Healthcare LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| NxStage Medical, Inc. | 1 | $19 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
| Aurinia Pharma U.S., Inc. | 1 | $17 |
Products named: Fabhalta, Vanrafia, Kerendia, FABRAZYME, FUROSCIX, Renal - PD, JYNARQUE, LIBERTY SELECT CYCLER.
Industry payments across SD — which companies pay providers there.
